BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 30114351)

  • 1. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
    Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
    ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies.
    Yuan J; Li L; Yang Q; Ran H; Wang J; Hu K; Pu W; Huang J; Wen L; Zhou L; Jiang Y; Xiong X; Zhang J; Zhou Z
    ACS Nano; 2021 Oct; 15(10):16076-16094. PubMed ID: 34606239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Broad-Spectrum ROS-Eliminating Material for Prevention of Inflammation and Drug-Induced Organ Toxicity.
    Li L; Guo J; Wang Y; Xiong X; Tao H; Li J; Jia Y; Hu H; Zhang J
    Adv Sci (Weinh); 2018 Oct; 5(10):1800781. PubMed ID: 30356945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary circulation-mediated heart targeting for the prevention of heart failure by inhalation of intrinsically bioactive nanoparticles.
    Liu C; Chen L; Ma Y; Hu K; Wu P; Pan L; Chen H; Li L; Hu H; Zhang J
    Theranostics; 2021; 11(17):8550-8569. PubMed ID: 34373758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin.
    Cheraga N; Ye Z; Xu MJ; Zou L; Sun NC; Hang Y; Shan CJ; Yang ZZ; Chen LJ; Huang NP
    Nanoscale; 2022 Jun; 14(24):8709-8726. PubMed ID: 35673987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
    Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
    Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease.
    Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J
    Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic ditempolphosphatidylcholine liposome-like nanoparticles for anti-oxidative therapy of atherosclerosis.
    Wang C; Zhao R; Wang Z; Xu T; Huang P
    RSC Adv; 2023 May; 13(24):16211-16221. PubMed ID: 37266511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis.
    Zhang Y; Yin Y; Zhang W; Li H; Wang T; Yin H; Sun L; Su C; Zhang K; Xu H
    J Nanobiotechnology; 2021 May; 19(1):161. PubMed ID: 34059078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Respiration Is Reduced in Atherosclerosis, Promoting Necrotic Core Formation and Reducing Relative Fibrous Cap Thickness.
    Yu EPK; Reinhold J; Yu H; Starks L; Uryga AK; Foote K; Finigan A; Figg N; Pung YF; Logan A; Murphy MP; Bennett M
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2322-2332. PubMed ID: 28970293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice.
    Wu Y; Xie G; Xu Y; Ma L; Tong C; Fan D; Du F; Yu H
    J Transl Med; 2015 Sep; 13():316. PubMed ID: 26410585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
    Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
    EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE
    Yan J; Li M; Wang XD; Lu ZY; Ni XL
    Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation.
    Menini S; Iacobini C; Ricci C; Scipioni A; Blasetti Fantauzzi C; Giaccari A; Salomone E; Canevotti R; Lapolla A; Orioli M; Aldini G; Pugliese G
    Br J Pharmacol; 2012 Jun; 166(4):1344-56. PubMed ID: 22229552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice.
    Dou Y; Guo J; Chen Y; Han S; Xu X; Shi Q; Jia Y; Liu Y; Deng Y; Wang R; Li X; Zhang J
    J Control Release; 2016 Aug; 235():48-62. PubMed ID: 27235978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Characterization of Fucoidan-Chitosan Nanoparticles Targeting P-Selectin for Effective Atherosclerosis Therapy.
    Liu M; Zhang Y; Ma X; Zhang B; Huang Y; Zhao J; Wang S; Li Y; Zhu Y; Xiong J; He T; Wang Y; Han W; Yang K; Bi X; Liu Y; Zhang H
    Oxid Med Cell Longev; 2022; 2022():8006642. PubMed ID: 36120595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Cascade Nanozymes with Antisenescence Activities for Atherosclerosis Therapy.
    Liu W; Zhang Y; Wei G; Zhang M; Li T; Liu Q; Zhou Z; Du Y; Wei H
    Angew Chem Int Ed Engl; 2023 Aug; 62(33):e202304465. PubMed ID: 37338457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.